Your browser doesn't support javascript.
loading
Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insights.
Leo, Chen Huei; Ng, Hooi Hooi; Marshall, Sarah A; Jelinic, Maria; Rupasinghe, Thusitha; Qin, Chengxue; Roessner, Ute; Ritchie, Rebecca H; Tare, Marianne; Parry, Laura J.
Afiliação
  • Leo CH; School of Biosciences, The University of Melbourne, Parkville, VIC, Australia.
  • Ng HH; School of Biosciences, The University of Melbourne, Parkville, VIC, Australia.
  • Marshall SA; Heart Failure Pharmacology, Baker Heart & Diabetes Institute, Melbourne, VIC, Australia.
  • Jelinic M; School of Biosciences, The University of Melbourne, Parkville, VIC, Australia.
  • Rupasinghe T; School of Biosciences, The University of Melbourne, Parkville, VIC, Australia.
  • Qin C; Metabolomics Australia, School of Biosciences, The University of Melbourne, Parkville, VIC, Australia.
  • Roessner U; Heart Failure Pharmacology, Baker Heart & Diabetes Institute, Melbourne, VIC, Australia.
  • Ritchie RH; Department of Pharmacology & Therapeutics, The University of Melbourne, Parkville, VIC, Australia.
  • Tare M; School of Biosciences, The University of Melbourne, Parkville, VIC, Australia.
  • Parry LJ; Metabolomics Australia, School of Biosciences, The University of Melbourne, Parkville, VIC, Australia.
Br J Pharmacol ; 177(1): 217-233, 2020 01.
Article em En | MEDLINE | ID: mdl-31479151

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Relaxina / Vasoconstrição / Endotélio Vascular / Hipertensão Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Relaxina / Vasoconstrição / Endotélio Vascular / Hipertensão Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article